Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition

Valentina Kon; Agnes B. Fogo; Iekuni Ichikawa; Samuel Hellings; Teresa Bills

doi:10.1038/ki.1993.279

Keywords

EndocrinologyInternal medicineBradykininAngiotensin-converting enzymeFiltration fractionAngiotensin IIRenal functionChemistryRenin–angiotensin systemACE inhibitorRenal blood flowMedicineBlood pressureReceptor

Affiliated Institutions

Vanderbilt University US

Related Publications

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario , Jewell A. Jessup , Mark C. Chappell +5 more

Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...

2005 Circulation 1598 citations

Concomitant Angiotensin AT1 Receptor Antagonism and Neprilysin Inhibition Produces Omapatrilat-like Antihypertensive Effects Without Promoting Tracheal Plasma Extravasation in the Rat

Laxminarayan G. Hegde , Cecile Yu , Travis Renner +11 more

Dual inhibition of angiotensin-converting enzyme (ACE) and neprilysin (NEP) by drugs such as omapatrilat produces superior antihypertensive efficacy but cause high incidence of ...

2011 Journal of Cardiovascular Pharmacology 63 citations

Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2

Lili Huang , Daniel J. Sexton , Kirsten Skogerson +13 more

Angiotensin-converting enzyme 2 (ACE2), a recently identified human homolog of ACE, is a novel metallocarboxypeptidase with specificity, tissue distribution, and function distin...

2003 Journal of Biological Chemistry 219 citations

Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition

Nicholas L. Cruden , Keith A.A. Fox , Christopher A. Ludlam +2 more

Angiotensin-converting enzyme and neutral endopeptidase (EC 3.4.24.11; neprilysin) are metallopeptidases present on the endothelium that metabolize bradykinin. Inhibitors of ang...

2004 Hypertension 77 citations

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin‐mediated angioedema

Ryan M. Fryer , Jason A. Segreti , Patricia N. Banfor +8 more

Background and purpose: Inhibition of bradykinin metabolizing enzymes (BMEs) can cause acute angioedema, as demonstrated in a recent clinical trial in patients administered the ...

2007 British Journal of Pharmacology 129 citations

Publication Info

Year: 1993
Type: article
Volume: 44
Issue: 3
Pages: 545-550
Citations: 201
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

201

OpenAlex

Cite This

APA Style

                            
                                
                                    Valentina Kon, 
                                
                                    Agnes B. Fogo, 
                                
                                    Iekuni Ichikawa
                                
                                et al.
                            
                            (1993). 
                            Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. 
                            Kidney International
                            , 44
                            (3)
                            , 545-550.
                            https://doi.org/10.1038/ki.1993.279
                        

Identifiers

DOI: 10.1038/ki.1993.279